Novel tobacco products such as electronic cigarettes and heated tobacco are increasingly replacing traditional cigarettes, which according to the World Health Organisation, cost Europe nearly 700,000 deaths every year.

Citing several worldwide studies, their advocates insist these products are much less harmful compared to traditional smoking and, therefore, should be used as harm reduction products.

On the other hand, the EU and a large part of the scientific community remain cautious, emphasising the lack of clear evidence regarding their long-term effects.

In this special report, EURACTIV will examine several aspects related to these products, ranging from the ongoing debate over the need for an EU-wide tobacco harm reduction strategy to the tobacco excise tax and to what extent EU policymakers rely on science when it comes to decision making.

Leave a Reply